http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0250118-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55070ae1bfc0270ee1da63b991809d21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9c71c1ebb77ac885f2f36f9a82a4ef0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e91ad1c2ebc3293c517277205b61f82f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b210425bdb356f734a10d5f0b0c7fafd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_469e7913e6e16344ccd563784099badb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-626
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
filingDate 2001-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5874e0f365742e7c571de7f8ac848eae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2874238dd3dc42af10a29eac917d46ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8293f22434b22f41ac5044bf97da36f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a35159ad12b4b587c70e5b9a273a567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5c8237c9e985c266e8d17a0f5c4a0be
publicationDate 2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0250118-A2
titleOfInvention Single-strand antibody with improved stability
abstract A single-strand antibody is disclosed, characterised in that the C- or N-terminus of the VH domain is connected to the N- or C-terminus of the VL domain, without a linker, whereby the VH domain comprises a deletion of at least one amino acid normally occurring at the C- or N-terminus thereof and/or the VL domain comprises a deletion of at least one amino acid normally occurring at the N- or C-terminus thereof, preferably with merely the VH domain of the single strand antibody comprising a deletion of the amino acid normally forming the C-terminus. A markedly improved stability of the antibody on storage can thus be achieved and also an improved half-life time in plasma is achieved.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3636660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8426675-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016196344-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8323653-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9260530-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9896505-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883992-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2590642-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8444973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8137907-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3660035-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7993925-B2
priorityDate 2000-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5366546

Total number of triples: 47.